Sfmg, LLC Incyte Corp Transaction History

Sfmg, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $169,799 - $218,941	-1,996 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$74.18 - $108.93 $148,063 - $217,424	1,996 New	1,996 $208,000
Q1 2020 May 08, 2020	SELL	$63.18 - $85.97 $1.74 Million - $2.37 Million	-27,545 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$73.04 - $95.72 $169,818 - $222,549	2,325 Added 9.22%	27,545 $2.41 Million
Q3 2019 Oct 29, 2019	BUY	$72.82 - $86.52 $526,197 - $625,193	7,226 Added 40.16%	25,220 $1.87 Million
Q2 2019 Aug 05, 2019	BUY	$73.52 - $88.7 $1.32 Million - $1.6 Million	17,994 New	17,994 $1.44 Million

641

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

Stay updated on Sfmg, LLC with notifications on news.